摘要
目的分析和对比不同他汀类药物治疗早发冠心病急性心肌梗死患者的近期疗效。方法将我院2014年3月-2015年9月收治的68例早发冠心病急性心肌梗死患者随机分为观察组（瑞舒伐他汀）和对照组（阿托伐他汀）各34例,观察其治疗效果。结果观察组患者的TC、hs-CRP以及LDL-C等指标均优于对照组（P〈0.05）,两组患者的治疗有效率差异无统计学意义（P〉0.05）。结论瑞舒伐他汀与阿托伐他汀治疗早发冠心病急性心肌梗死患者近期疗效相近,但是瑞舒伐他汀作用效果更加全面。
Objective Analysis and comparison of different statins in the treatment of acute myocardial infarction in patients with early coronary heart disease. Methods 68 cases of premature coronary heart disease with acute myocardial infarction were randomly divided into observation group（rosuvastatin）and control group（atorvastatin）in our hospital from March 2014 to September 2015,34 cases in each. The therapeutic effect was observed. Results The observation group of patients with TC,hs-CRP,LDL-C and other indicators were significantly better than the control group（P〈0.05）. There was no significant difference in the effective rate between the two groups（P〈0.05）. Conclusion Rosuvastatin and atorvastatin in the treatment of premature coronary heart disease in patients with acute myocardial infarction of curative effect is similar,but the effect of rosuvastatin is more comprehensive.
出处
《中国卫生标准管理》
2016年第20期127-128,共2页
China Health Standard Management
关键词
他汀类药物
早发冠心病
急性心肌梗死
近期疗效
Statins
Premature coronary heart disease
Acute myocardial infarction
Recent curative effect
